PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Accepted for Presentations at Major Conferences, page-11

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Wow isn't that something. More precise tools = higher barrier of entry for generics - another layer of protection.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.